← Eichor
Condition: Mesial Temporal Lobe Epilepsy Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Mesial Temporal Lobe Epilepsy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
Phase 1/Phase 2 · 18 location(s) · UniQure Biopharma B.V. · NCT06063850MRgLITT for mTLE: A PROBE Trial
NA · 1 location(s) · Beijing Tiantan Hospital · NCT06720922A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)
Phase 1/Phase 2 · 17 location(s) · Neurona Therapeutics · NCT06422923Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell T
Phase 3 · 35 location(s) · Neurona Therapeutics · NCT05135091Pharmacological Modulation of Brain Oscillations in Memory Processing
EARLY_Phase 1 · 1 location(s) · University of Texas Southwestern Medical Center · NCT05594017PRIME: PReservIng Memory in Epilepsy
NA · 2 location(s) · Nitin Tandon · NCT05608408Exploratory Study of UX-GIP001 Cell Therapy in Adult Patients With Drug-Resistant Unilateral Mesial Temporal Lobe Epilep
EARLY_Phase 1 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07244328
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.